vs

Side-by-side financial comparison of ELBIT SYSTEMS LTD (ESLT) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

ELBIT SYSTEMS LTD is the larger business by last-quarter revenue ($5.8M vs $5.0M, roughly 1.2× cbdMD, Inc.). ELBIT SYSTEMS LTD runs the higher net margin — 6.3% vs -5.6%, a 12.0% gap on every dollar of revenue. ELBIT SYSTEMS LTD produced more free cash flow last quarter ($319.6K vs $-977.3K).

Elbit Systems Ltd. is an Israel-based international military technology company and defense contractor. Founded in 1966 by Elron, Elbit Systems is the primary provider of the Israeli military's land-based equipment and unmanned aerial vehicles. It is an important company within the defense industry of Israel.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

ESLT vs YCBD — Head-to-Head

Bigger by revenue
ESLT
ESLT
1.2× larger
ESLT
$5.8M
$5.0M
YCBD
Higher net margin
ESLT
ESLT
12.0% more per $
ESLT
6.3%
-5.6%
YCBD
More free cash flow
ESLT
ESLT
$1.3M more FCF
ESLT
$319.6K
$-977.3K
YCBD

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
ESLT
ESLT
YCBD
YCBD
Revenue
$5.8M
$5.0M
Net Profit
$367.1K
$-283.1K
Gross Margin
24.3%
59.8%
Operating Margin
8.3%
-5.7%
Net Margin
6.3%
-5.6%
Revenue YoY
-1.9%
Net Profit YoY
-1975.7%
EPS (diluted)
$7.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESLT
ESLT
YCBD
YCBD
Q4 25
$5.0M
Q3 25
$5.8M
$4.7M
Q2 25
$4.6M
Q1 25
$4.7M
Q4 24
$5.1M
Q3 24
$4.6M
Q2 24
$5.2M
Q1 24
$4.4M
Net Profit
ESLT
ESLT
YCBD
YCBD
Q4 25
$-283.1K
Q3 25
$367.1K
$-680.0K
Q2 25
$-895.3K
Q1 25
$-480.8K
Q4 24
$15.1K
Q3 24
$-152.8K
Q2 24
$459.7K
Q1 24
$-3.0M
Gross Margin
ESLT
ESLT
YCBD
YCBD
Q4 25
59.8%
Q3 25
24.3%
58.8%
Q2 25
61.5%
Q1 25
62.3%
Q4 24
66.5%
Q3 24
53.9%
Q2 24
65.8%
Q1 24
59.0%
Operating Margin
ESLT
ESLT
YCBD
YCBD
Q4 25
-5.7%
Q3 25
8.3%
-14.5%
Q2 25
-19.6%
Q1 25
-10.2%
Q4 24
-1.7%
Q3 24
-6.9%
Q2 24
-7.4%
Q1 24
-35.4%
Net Margin
ESLT
ESLT
YCBD
YCBD
Q4 25
-5.6%
Q3 25
6.3%
-14.4%
Q2 25
-19.4%
Q1 25
-10.1%
Q4 24
0.3%
Q3 24
-3.4%
Q2 24
8.9%
Q1 24
-68.8%
EPS (diluted)
ESLT
ESLT
YCBD
YCBD
Q4 25
Q3 25
$7.85
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-0.15
Q1 24
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESLT
ESLT
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$265.4K
$3.4M
Total DebtLower is stronger
$90.7K
Stockholders' EquityBook value
$3.3M
$9.0M
Total Assets
$11.0M
$11.8M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESLT
ESLT
YCBD
YCBD
Q4 25
$3.4M
Q3 25
$265.4K
$2.3M
Q2 25
$1.1M
Q1 25
$1.8M
Q4 24
$2.0M
Q3 24
$2.5M
Q2 24
$2.4M
Q1 24
$2.1M
Total Debt
ESLT
ESLT
YCBD
YCBD
Q4 25
Q3 25
$90.7K
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ESLT
ESLT
YCBD
YCBD
Q4 25
$9.0M
Q3 25
$3.3M
$7.2M
Q2 25
$6.1M
Q1 25
$665.8K
Q4 24
$1.8M
Q3 24
$2.0M
Q2 24
$3.0M
Q1 24
$3.1M
Total Assets
ESLT
ESLT
YCBD
YCBD
Q4 25
$11.8M
Q3 25
$11.0M
$10.4M
Q2 25
$9.9M
Q1 25
$10.9M
Q4 24
$11.5M
Q3 24
$10.6M
Q2 24
$13.8M
Q1 24
$14.6M
Debt / Equity
ESLT
ESLT
YCBD
YCBD
Q4 25
Q3 25
0.03×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESLT
ESLT
YCBD
YCBD
Operating Cash FlowLast quarter
$534.6K
$-812.5K
Free Cash FlowOCF − Capex
$319.6K
$-977.3K
FCF MarginFCF / Revenue
5.5%
-19.5%
Capex IntensityCapex / Revenue
3.7%
3.3%
Cash ConversionOCF / Net Profit
1.46×
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESLT
ESLT
YCBD
YCBD
Q4 25
$-812.5K
Q3 25
$534.6K
$-240.7K
Q2 25
$-704.2K
Q1 25
$-189.5K
Q4 24
$-317.9K
Q3 24
$167.4K
Q2 24
$289.8K
Q1 24
$-704.1K
Free Cash Flow
ESLT
ESLT
YCBD
YCBD
Q4 25
$-977.3K
Q3 25
$319.6K
$-243.6K
Q2 25
$-705.7K
Q1 25
$-205.0K
Q4 24
$-482.3K
Q3 24
$157.4K
Q2 24
Q1 24
$-708.7K
FCF Margin
ESLT
ESLT
YCBD
YCBD
Q4 25
-19.5%
Q3 25
5.5%
-5.2%
Q2 25
-15.3%
Q1 25
-4.3%
Q4 24
-9.4%
Q3 24
3.5%
Q2 24
Q1 24
-16.2%
Capex Intensity
ESLT
ESLT
YCBD
YCBD
Q4 25
3.3%
Q3 25
3.7%
0.1%
Q2 25
0.0%
Q1 25
0.3%
Q4 24
3.2%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
ESLT
ESLT
YCBD
YCBD
Q4 25
Q3 25
1.46×
Q2 25
Q1 25
Q4 24
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESLT
ESLT

Segment breakdown not available.

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons